YoungHeartValve is a Polymeric Hyaluronan-Enhanced Transcatheter Aortic Valves which were developed by engineers by inspiration from nature.
YoungHeartValve has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in October 2024.
YoungHeartValve's investors include National Institutes of Health.
YoungHeartValve is headquartered in Atlanta, United States.
YoungHeartValve is a Polymeric Hyaluronan-Enhanced Transcatheter Aortic Valves which were developed by engineers by inspiration from nature.
YoungHeartValve is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"YoungHeartValve — Funding & Investors." VCBacked, October 25, 2024, https://www.vcbacked.co/company/youngheartvalve. Accessed July 19, 2026.
VCBacked. (2024). YoungHeartValve — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/youngheartvalve
{{cite web |title=YoungHeartValve — Funding & Investors |url=https://www.vcbacked.co/company/youngheartvalve |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated